ScoreWhy is Xvivo Perfusion AB ?
1
With a fall in Net Sales of -0.62%, the company declared Very Negative results in Dec 25
- The company has declared negative results in Mar 25 after 8 consecutive negative quarters
- INTEREST(9M) At SEK 13.57 MM has Grown at 1,637.52%
- ROCE(HY) Lowest at 1.18%
- DEBT-EQUITY RATIO (HY) Highest at -7.92 %
2
With ROE of 6.44%, it has a expensive valuation with a 2.42 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -30.78%, its profits have risen by 2.8% ; the PEG ratio of the company is 13.6
3
Underperformed the market in the last 1 year
- Even though the market (OMX Stockholm 30) has generated returns of 10.97% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -30.78% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Xvivo Perfusion AB for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Xvivo Perfusion AB
-30.78%
20.52
59.52%
OMX Stockholm 30
10.97%
0.59
18.59%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
35.19%
EBIT Growth (5y)
47.44%
EBIT to Interest (avg)
3.87
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
0.36
Tax Ratio
12.12%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.93%
ROE (avg)
3.50%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
38
Industry P/E
Price to Book Value
2.42
EV to EBIT
47.37
EV to EBITDA
25.50
EV to Capital Employed
2.67
EV to Sales
5.77
PEG Ratio
13.58
Dividend Yield
NA
ROCE (Latest)
5.64%
ROE (Latest)
6.44%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -5.86% (YoY
-22What is not working for the Company
INTEREST(9M)
At SEK 13.57 MM has Grown at 1,637.52%
ROCE(HY)
Lowest at 1.18%
DEBT-EQUITY RATIO
(HY)
Highest at -7.92 %
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.17 times
PRE-TAX PROFIT(Q)
At SEK 41.19 MM has Fallen at -41.76%
NET PROFIT(Q)
At SEK 31.65 MM has Fallen at -38.98%
Here's what is working for Xvivo Perfusion AB
Raw Material Cost
Fallen by -5.86% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Xvivo Perfusion AB
Interest
At SEK 13.57 MM has Grown at 1,637.52%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SEK MM)
Pre-Tax Profit
At SEK 41.19 MM has Fallen at -41.76%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (SEK MM)
Net Profit
At SEK 31.65 MM has Fallen at -38.98%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (SEK MM)
Debt-Equity Ratio
Highest at -7.92 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Inventory Turnover Ratio
Lowest at 1.17 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
